Hypoxia-induced Long Non-coding RNA DARS-AS1 Regulates RBM39 Stability to Promote Myeloma Malignancy

Overview

Journal Haematologica

Specialty Hematology

Date 2019 Jul 11

PMID 31289203

Citations 34

Authors

Jia Tong

Xiaoguang Xu

Zilu Zhang

Chengning Ma

Rufang Xiang

Jia Liu

Wenbin Xu

Chao Wu

Junmin Li

Fenghuang Zhan

Yingli Wu

Hua Yan

Affiliations

Soon will be listed here.

Abstract

Multiple myeloma is a malignant plasma-cell disease, which is highly dependent on the hypoxic bone marrow microenvironment. However, the underlying mechanisms of hypoxia contributing to myeloma genesis are not fully understood. Here, we show that long non-coding RNA DARS-AS1 in myeloma is directly upregulated by hypoxia inducible factor (HIF)-1. Importantly, DARS-AS1 is required for the survival and tumorigenesis of myeloma cells both and DARS-AS1 exerts its function by binding RNA-binding motif protein 39 (RBM39), which impedes the interaction between RBM39 and its E3 ubiquitin ligase RNF147, and prevents RBM39 from degradation. The overexpression of RBM39 observed in myeloma cells is associated with poor prognosis. Furthermore, knockdown of DARS-AS1 inhibits the mammalian target of rapamycin signaling pathway, an effect that is reversed by RBM39 overexpression. We reveal that a novel HIF-1/DARS-AS1/RBM39 pathway is implicated in the pathogenesis of myeloma. Targeting DARS-AS1/RBM39 may, therefore, represent a novel strategy to combat myeloma.

Citing Articles

Landscape of Noncoding RNA in the Hypoxic Tumor Microenvironment.

Gong L, Zou C, Zhang H, Yang F, Qi G, Ma Z Genes (Basel). 2025; 16(2).

PMID: 40004471 PMC: 11855738. DOI: 10.3390/genes16020140.

Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin.

Wang J, Zheng L, Chen W, Zhang X, Lv D, Zeng C Oncogene. 2024; 44(9):575-586.

PMID: 39633066 DOI: 10.1038/s41388-024-03242-7.

Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies.

Pomella S, Melaiu O, Cifaldi L, Bei R, Gargari M, Campanella V Int J Mol Sci. 2024; 25(16).

PMID: 39201614 PMC: 11354375. DOI: 10.3390/ijms25168929.

MORC2 regulates RBM39-mediated CDK5RAP2 alternative splicing to promote EMT and metastasis in colon cancer.

He Y, Shao Y, Zhou Z, Li T, Gao Y, Liu X Cell Death Dis. 2024; 15(7):530.

PMID: 39048555 PMC: 11269669. DOI: 10.1038/s41419-024-06908-y.

Highlighting the role of long non-coding RNA (LncRNA) in multiple myeloma (MM) pathogenesis and response to therapy.

Al-Hawary S, Jasim S, Altalbawy F, Hjazi A, Jyothi S, Kumar A Med Oncol. 2024; 41(7):171.

PMID: 38849654 DOI: 10.1007/s12032-024-02392-8.

References

Qin W, Li X, Xie L, Li S, Liu J, Jia L . A long non-coding RNA, APOA4-AS, regulates APOA4 expression depending on HuR in mice. Nucleic Acids Res. 2016; 44(13):6423-33. PMC: 5291254. DOI: 10.1093/nar/gkw341. View

Kornienko A, Guenzl P, Barlow D, Pauler F . Gene regulation by the act of long non-coding RNA transcription. BMC Biol. 2013; 11:59. PMC: 3668284. DOI: 10.1186/1741-7007-11-59. View

McInturff A, Cody M, Elliott E, Glenn J, Rowley J, Rondina M . Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 α. Blood. 2012; 120(15):3118-25. PMC: 3471519. DOI: 10.1182/blood-2012-01-405993. View

Zhu Q, Wang H, Jiang B, Ni X, Jiang L, Li C . Loss of ATF3 exacerbates liver damage through the activation of mTOR/p70S6K/ HIF-1α signaling pathway in liver inflammatory injury. Cell Death Dis. 2018; 9(9):910. PMC: 6125320. DOI: 10.1038/s41419-018-0894-1. View

Dowhan D, Hong E, Auboeuf D, Dennis A, Wilson M, Berget S . Steroid hormone receptor coactivation and alternative RNA splicing by U2AF65-related proteins CAPERalpha and CAPERbeta. Mol Cell. 2005; 17(3):429-39. DOI: 10.1016/j.molcel.2004.12.025. View

Tsai M, Spitale R, Chang H . Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011; 71(1):3-7. PMC: 3057914. DOI: 10.1158/0008-5472.CAN-10-2483. View

Maiso P, Huynh D, Moschetta M, Sacco A, Aljawai Y, Mishima Y . Metabolic signature identifies novel targets for drug resistance in multiple myeloma. Cancer Res. 2015; 75(10):2071-82. PMC: 4433568. DOI: 10.1158/0008-5472.CAN-14-3400. View

Qu A, Taylor M, Xue X, Matsubara T, Metzger D, Chambon P . Hypoxia-inducible transcription factor 2α promotes steatohepatitis through augmenting lipid accumulation, inflammation, and fibrosis. Hepatology. 2011; 54(2):472-83. PMC: 3145012. DOI: 10.1002/hep.24400. View

Kim M, Hur J, Jeong S . Emerging roles of RNA and RNA-binding protein network in cancer cells. BMB Rep. 2009; 42(3):125-30. DOI: 10.5483/bmbrep.2009.42.3.125. View

10.

Ulitsky I, Bartel D . lincRNAs: genomics, evolution, and mechanisms. Cell. 2013; 154(1):26-46. PMC: 3924787. DOI: 10.1016/j.cell.2013.06.020. View

11.

Na S, Na D, Lee J . Molecular cloning and characterization of CAPER, a novel coactivator of activating protein-1 and estrogen receptors. J Biol Chem. 2001; 277(2):1229-34. DOI: 10.1074/jbc.M110417200. View

12.

Mercer T, Dinger M, Mattick J . Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009; 10(3):155-9. DOI: 10.1038/nrg2521. View

13.

Villegas V, Zaphiropoulos P . Neighboring gene regulation by antisense long non-coding RNAs. Int J Mol Sci. 2015; 16(2):3251-66. PMC: 4346893. DOI: 10.3390/ijms16023251. View

14.

Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T . Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011; 71(20):6320-6. DOI: 10.1158/0008-5472.CAN-11-1021. View

15.

Zheng J, Huang X, Tan W, Yu D, Du Z, Chang J . Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. Nat Genet. 2016; 48(7):747-57. DOI: 10.1038/ng.3568. View

16.

Han T, Goralski M, Gaskill N, Capota E, Kim J, Ting T . Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. Science. 2017; 356(6336). DOI: 10.1126/science.aal3755. View

17.

Mai S, Qu X, Li P, Ma Q, Cao C, Liu X . Global regulation of alternative RNA splicing by the SR-rich protein RBM39. Biochim Biophys Acta. 2016; 1859(8):1014-24. DOI: 10.1016/j.bbagrm.2016.06.007. View

18.

Sillars-Hardebol A, Carvalho B, Tijssen M, Belien J, de Wit M, Delis-van Diemen P . TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression. Gut. 2011; 61(11):1568-75. DOI: 10.1136/gutjnl-2011-301153. View

19.

Taniue K, Kurimoto A, Sugimasa H, Nasu E, Takeda Y, Iwasaki K . Long noncoding RNA UPAT promotes colon tumorigenesis by inhibiting degradation of UHRF1. Proc Natl Acad Sci U S A. 2016; 113(5):1273-8. PMC: 4747749. DOI: 10.1073/pnas.1500992113. View

20.

Huang G, Zhou Z, Wang H, Kleinerman E . CAPER-α alternative splicing regulates the expression of vascular endothelial growth factor₁₆₅ in Ewing sarcoma cells. Cancer. 2011; 118(8):2106-16. PMC: 3262942. DOI: 10.1002/cncr.26488. View